PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SoaanzTorsemide2021-06-142033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
malnutrition
,
therapeutic equivalency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
biotransformation
,
food-drug interactions
,
body weight
,
body weight changes
,
healthy volunteers/patients
,
disease
,
pre-eclampsia
,
overactive urinary bladder
,
urinary incontinence
,
genetic predisposition to disease
,
heart failure
,
hypertension
,
edema
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
cardiovascular diseases
,
tricuspid valve insufficiency
,
fibrosis
,
mitral valve insufficiency
,
covid-19
,
drug-related side effects and adverse reactions
,
drug interactions
Sodium chloride
healthy volunteers/patients
,
atherosclerosis
,
infections
,
hepatitis b
,
chronic hepatitis b
,
communicable diseases
,
virus diseases
,
hepatitis
,
herpesviridae infections
,
hepatitis a
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
hemorrhage
,
subarachnoid hemorrhage
,
malignant mesothelioma
,
mesothelioma
,
non-hodgkin lymphoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
colorectal neoplasms
,
uterine cervical neoplasms
,
covid-19
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
carcinoma
,
transitional cell carcinoma
,
multiple sclerosis
,
sclerosis
,
rheumatoid arthritis
,
arthritis
,
relapsing-remitting multiple sclerosis
,
recurrence
,
chronic progressive multiple sclerosis
,
ulcerative colitis
,
colitis
,
ulcer
,
osteoarthritis
,
pleural empyema
,
empyema
,
graft rejection
,
giant cell arteritis
,
polymyalgia rheumatica
,
kidney transplantation
,
heart failure
,
drug-related side effects and adverse reactions
,
renal insufficiency
,
thrombosis
,
hiv infections
,
osteoporosis
,
hip fractures
,
bone fractures
,
hypertension
,
cardiovascular diseases
,
health risk behaviors
,
vascular stiffness
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use